Research and Science at HM Hospitales
Our way of working is closely tied to our founding purpose: to combine healthcare and research efforts in projects that benefit our patients.
Fundacion HM research programs
This has allowed us to establish working programs led by research doctors, who raise the problems they encounter in clinical practice and, with the support of multi-disciplinary teams, help find solutions through basic research, the results of which benefit thousands of patients.
- Oncology
- Cardiology
- Neuroscience
- General Surgery
- Maxillofacial Surgery
- Pain Unit
- Rheumatology
- Internal Medicine
- Traumatology
- Gynaecology
- Anaesthetics
Clinical Trials
Since it was started up in 2008, the Unidad Central de Ensayos Clínicos (UCEC) (the Clinical Trials Unit) has opened more than 460 clinical trials. Last year, more than 500 patients took part in these studies. The UCEC is located at Hospital Universitario HM Sanchinarro.
The following clinical trials are currently open at the UCEC, grouped into the Units that comprise it, and by line of treatment or medical indication.
- Head and Neck Cancer Unit
- Breast Cancer Unit
- Prostate Cancer Unit
- Lung Cancer Unit
- Gastrointestinal Cancer Unit
- Gynaecological, Genitourinary and Skin Cancer Unit
- Endocrinology Unit
- Gynaecology Unit
- Paediatrics Unit
- Internal Medicine Unit
- Vascular Surgery Unit
- Rheumatology Unit
- Phase I Unit - START Madrid
- Haematology Unit
- Nephrology Unit
- Neuro-Oncology Unit
- Paediatric Oncology Unit
Biological Sample Bank
The Biobank of the HM Hospitales Group is a non-profit unit intended to support research, governed by Law 14/2007 on Biomedical Research (LIB) and Royal Decree 1416/2011 (RD), establishing the basic requirements for authorization and operation of biobanks for biomedical research and for the management of human biological samples, and regulating the operation and organization of the National Registry of Biobanks for biomedical research.
Therapeutic Targets Laboratory
This laboratory uses cutting-edge technological platforms, including massive cancer sequencing, to adapt cancer patients' treatment to the molecular profile of the tumours. It's a reference center in personalized medicine and offers internationally renowned continuing education.